More News
3 February 2014
ABLYNX ANNOUNCES WORLDWIDE CANCER IMMUNOTHERAPY DISCOVERY COLLABORATION AND LICENSING AGREEMENT WITH MERCK1 February 2014
Progenics 1404 Imaging Agent Shows High Accuracy in Detecting Cancer Within the Prostate Gland in Interim Analysis of Phase 2 Study31 January 2014
Edison Pharmaceuticals, Inc. enters into strategic alliance with Dainippon Sumitomo Pharma Co., Ltd.30 January 2014
iBio Adds Biotherapeutic Product for Treatment of Fibrosis to Its Proprietary Product Pipeline30 January 2014
Baxter Announces Restructured Agreement with Xenetic Biosciences, Further Bolstering Its Broad Bleeding Disorder Pipeline30 January 2014
UCB and Biogen Idec Enter Agreement To Commercialize Multiple Sclerosis and Hemophilia Therapies in Asia29 January 2014
Quest PharmaTech Announces Third Combinatorial Immunotherapy Clinical Trial for Oregovomab with a TLR3 agonist, Hiltonol28 January 2014
Celsion Corporation Announces Updated Overall Survival Results from Phase III HEAT Study of ThermoDox® in Primary Liver Cancer28 January 2014
Promising Class of Antibiotics Discovered for Treatment of Drug-Resistant Tuberculosis28 January 2014
FOB Synthesis, Inc. Announces Option and License Agreement with AstraZeneca on Treatment of Antibiotic-Resistant Bacterial Infections27 January 2014
Medigene acquires Trianta Immunotherapies22 January 2014
Nuevolution Enter Drug Discovery Collaboration with The Institute of Cancer Research (ICR) and Cancer Research Technology (CRT)21 January 2014
TetraLogic Announces Licensing and Research Collaboration With Walter and Eliza Hall Institute of Medical Research21 January 2014
NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquired by Teva21 January 2014
BioLineRx Receives Approval to Commence Pivotal Trial for Novel Skin Lesion Treatment15 January 2014
Sanofi and Fraunhofer-Gesellschaft Announce the Creation of a Natural Product Center of Excellence15 January 2014
Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel DiseaseNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports